Denmark stocks lower at close of trade; OMX Copenhagen 20 down 3.59%

Investing.com – Denmark stocks were lower after the close on Monday, as losses in the , and sectors led shares lower.

At the close in Copenhagen, the lost 3.59%.

The best performers of the session on the were Genmab (CSE:), which fell 0.21% or 3.5 points to trade at 1701.5 at the close. Meanwhile, Coloplast A/S (CSE:) fell 2.17% or 20.8 points to end at 939.4 and Novo Nordisk A/S Class B (CSE:) was down 2.85% or 12.5 points to 426.2 in late trade.

The worst performers of the session were Royal Unibrew A/S (CSE:), which fell 6.81% or 46 points to trade at 632 at the close. DSV (CSE:) declined 6.47% or 50.0 points to end at 722.6 and Pandora A/S (CSE:) was down 6.44% or 21.4 points to 311.1.

Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 139 to 11 and 8 ended unchanged.

Crude oil for April delivery was down 5.17% or 2.76 to $50.62 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May fell 5.70% or 3.30 to hit $54.64 a barrel, while the April Gold Futures contract rose 1.66% or 27.45 to trade at $1676.25 a troy ounce.

USD/DKK was down 0.12% to 6.8769, while EUR/DKK rose 0.10% to 7.4717.

The US Dollar Index Futures was down 0.09% at 99.102.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.